7043-08-5 Usage
Uses
Used in Pharmaceutical Industry:
Pyrimidine, 4-amino-6-cyclopropyl(7CI,8CI) is used as a building block for the synthesis of various pharmaceuticals. Its cyclopropyl group contributes to the enhancement of biological activity and selectivity of the resulting compounds, making it a valuable tool in drug design and development.
Used in Agrochemical Industry:
Pyrimidine, 4-amino-6-cyclopropyl(7CI,8CI) is utilized as a key component in the development of agrochemicals. Its unique structure and properties allow for the creation of effective and targeted agrochemicals for various applications.
Used in Organic Materials Industry:
Pyrimidine, 4-amino-6-cyclopropyl(7CI,8CI) serves as a crucial component in the synthesis of organic materials. Its versatile structure and properties enable the development of innovative materials with specific characteristics for various applications.
Used in Medicinal Chemistry and Drug Discovery:
Pyrimidine, 4-amino-6-cyclopropyl(7CI,8CI) is employed as a valuable compound in medicinal chemistry and drug discovery. Its potential applications in this field include the development of new drugs and therapeutic agents, as well as the enhancement of existing ones through its cyclopropyl group's ability to improve biological activity and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 7043-08-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,4 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7043-08:
(6*7)+(5*0)+(4*4)+(3*3)+(2*0)+(1*8)=75
75 % 10 = 5
So 7043-08-5 is a valid CAS Registry Number.
7043-08-5Relevant academic research and scientific papers
PYRAZOLOPYRIDINES AND PYRAZOLOPYRIDINES AND THEIR USE AS TYK2 INHIBITORS
-
Page/Page column 178, (2012/06/01)
The invention provides compounds of Formula (I), stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula (I) and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy, as TYK2 Kinase inhibitors.
